Open AccessConcurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study
Author(s) -
Dora L.�W. Kwong,
Jonathan S. T. Sham,
Gordon K.�H. Au,
Daniel T. T. Chua,
Philip WaiKay Kwong,
Ashley Cheng,
P.M. Wu,
Martin Law,
Carol C.H. Kwok,
C. C. Yau,
K.Y. Wan,
Raymond TszTong Chan,
Damon Choy
Publication year - 2004
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2004.05.173
Subject(s) - medicine , nasopharyngeal carcinoma , vincristine , gastroenterology , chemotherapy , fluorouracil , hazard ratio , cisplatin , radiation therapy , nuclear medicine , cyclophosphamide , confidence interval
To study the efficacy of concurrent chemoradiotherapy (CRT) and adjuvant chemotherapy (AC) for nasopharyngeal carcinoma (NPC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom